静脉溶栓后血管内取栓的两种模式比较
该研究基于前瞻性登记数据,比较了急性前循环大血管闭塞性缺血性卒中患者在接受静脉溶栓后,经「溶栓后转运」模式与「直接到院」模式治疗的功能独立情况。结果显示,两组3个月功能独立比例无统计学显著差异,但转运组流程时间更长。
要点
- 溶栓后转运模式与直接到院模式在3个月功能独立上无显著差异。
- 转运组基线卒中严重程度较轻,但流程时间显著更长。
- 两种模式在再通率和症状性出血转化率上相似。
核心结论
- 溶栓后转运模式的患者同样从桥接治疗中获益,与直接到综合卒中中心治疗的患者相比无统计学显著差异。
研究设计与样本
- 研究采用前瞻性收集的登记数据,纳入2013年1月1日至2016年4月30日期间在Saint-Antoine和Tenon医院(溶栓后转运)或Fondation Rothschild医院(直接到院)住院的患者。
- 纳入标准为年龄大于18岁、接受桥接治疗的急性前循环大血管闭塞性缺血性卒中患者。
- 直接到院组159例接受机械取栓的患者中,100例为溶栓后转运,59例为直接到院溶栓。
临床怎么用
- 对于无现场机械取栓条件的医院,静脉溶栓后转运患者接受桥接治疗是可行的,功能结局与直接到院治疗无显著差异。
- 需注意溶栓后转运模式会导致发病至再通时间延长,应优化转运流程以减少延误。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Intravenous thrombolysis (IVT) followed by mechanical thrombectomy (MT) is recommended to treat acute ischemic stroke (AIS) with a large vessel occlusion (LVO). Most hospitals do not have on-site MT facilities, and most patients need to be transferred secondarily after IVT (drip and ship), which may have an effect on the neurologic outcome. OBJECTIVE: To compare the functional independence at 3 months between patients treated under the drip-and-ship paradigm and those treated on site (mothership). DESIGN, SETTING, AND PARTICIPANTS: This study used a prospectively gathered registry of patients with AIS to select patients admitted through the Saint-Antoine and Tenon (drip and ship) or the Fondation Rothschild (mothership) hospitals from January 1, 2013, through April 30, 2016. The study included patients older than 18 years treated with bridging therapy for AIS with LVO of the anterior circulation. Among the 159 patients who received MT at the mothership, 100 had been transferred after IVT from the drip-and-ship hospitals and 59 had received IVT on site. MAIN OUTCOMES AND MEASURES: The main outcome was 3-month functional independence (modified Rankin scale score ≤2). Both groups were compared using a multivariate linear model, including variables that were significantly different in the 2 groups. RESULTS: During the study period, 497 patients were hospitalized at the drip-and-ship and mothership hospitals for an AIS eligible to reperfusion therapy; 11 patients had a basilar artery occlusion and were excluded, leaving 100 patients in the drip-and-ship group (mean age, 73 years; age range, 60-81 years; 57 men [57.0%]) and 59 in the mothership group (mean age, 70 years; age range, 58-82 years; 29 men [49.2%]). The proportion of patients with a favorable neurologic outcome at 3 months was similar in both groups (drip and ship, 61 [61.0%]; mothership, 30 [50.8%]; P = .26), even after adjusting the analysis for the baseline National Institutes of Health Stroke Scale score, diffusion-weighted imaging Alberta Stroke Program Early Computed Tomography Score, and general anesthesia (P = .82). Patients had less severe conditions in the drip-and-ship group (median baseline National Institutes of Health Stroke Scale score, 15 vs 17 [P = .03]; median diffusion-weighted imaging Alberta Stroke Program Early Computed Tomography Score, 7.5 vs 7 [P = .05]). Process times were longer in the drip-and-ship group (onset-to-needle time, 150 vs 135 minutes; onset-to-puncture time, 248 vs 189 minutes; and onset-to-recanalization time, 297 vs 240 minutes; P < .001). Both groups were similar in terms of substantial recanalization (Thrombolysis in Cerebral Ischemia scores 2B to 3; drip and ship, 84 [84.0%]; mothership, 47 [79.7%]; P = .49) and symptomatic hemorrhagic transformation (drip and ship, 2 [2.0%]; mothership, 2 [3.4%]; P = .63). CONCLUSIONS AND RELEVANCE: This study found that patients treated under the drip-and-ship paradigm also benefit from bridging therapy, with no statistically significant difference compared with those treated directly in a comprehensive stroke center.
引用
- Gerschenfeld G, Muresan IP, Blanc R, et al. Two Paradigms for Endovascular Thrombectomy After Intravenous Thrombolysis for Acute Ischemic Stroke. JAMA Neurol. 2017. PMID: 28319240. doi:10.1001/jamaneurol.2016.5823
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。